Intrathoracic infections in Hodgkin lymphoma (HL) patients may cooperate with HL to trigger hemophagocytic lymphohistiocytosis: A retrospective study

por Zhou, Ji-Cheng, Tan, Bin-Bin, Huang, Yan, Wu, Yin-Ying, Bai, Zhen-Jie, Liang, Min-Lan, Zhao, Wei-Hua
Publicado 2022

Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma

por Bai, Shuheng, Wu, YinYing, Yan, Yanli, Shao, Shuai, Zhang, Jiangzhou, Liu, Jiaxin, Hui, Beina, Liu, Rui, Ma, Hailin, Zhang, Xiaozhi, Ren, Juan
Publicado 2020

The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma

por Bai, Shuheng, Wu, YinYing, Yan, Yanli, Kang, Haojing, Zhang, Jiangzhou, Ma, Wen, Gao, Ying, Hui, Beina, Li, Rong, Zhang, Xiaozhi, Ren, Juan
Publicado 2020

Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi

por Bai, Shuheng, Wu, YinYing, Yan, Yanli, Li, Rong, Kang, Haojing, Zhang, Jiangzhou, Ma, Wen, Gao, Ying, Hui, Beina, Ma, Hailin, Zhang, Xiaozhi, Ren, Juan
Publicado 2021

Long non‐coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR‐454 and ZEB1

por Wu, YinYing, Zhu, Bo, Yan, Yanli, Bai, Shuheng, Kang, Haojing, Zhang, Jiangzhou, Ma, Wen, Gao, Ying, Hui, Beina, Li, Rong, Zhang, Xiaozhi, Ren, Juan
Publicado 2021

Long non‐coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer

por Bai, Zhuanli, Wu, YinYing, Bai, Shuheng, Yan, Yanli, Kang, Haojing, Ma, Wen, Zhang, Jiangzhou, Gao, Ying, Hui, Beina, Ma, Hailin, Li, Rong, Zhang, Xiaozhi, Ren, Juan
Publicado 2020

Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients

por Yang, Jiao, Du, Xiang lin, Li, Shu ting, Wang, Bi yuan, Wu, Yin ying, Chen, Zhe ling, Lv, Meng, Shen, Yan wei, Wang, Xin, Dong, Dan feng, Li, Dan, Wang, Fan, Li, En xiao, Yi, Min, Yang, Jin
Publicado 2016

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma

por Wang, Xi, Zhang, Cheng-Sheng, Dong, Xu-Yuan, Hu, Yuan, Duan, Bao-Jun, Bai, Jun, Wu, Yin-Ying, Fan, Lin, Liao, Xin-Hua, Kang, Ye, Zhang, Peng, Li, Meng-Yang, Xu, Jiao, Mao, Zhi-Jun, Liu, Hui-Tong, Zhang, Xiao-Long, Tian, Li-Fei, Li, En-Xiao
Publicado 2022